"6"^^ . "Neuromuscular block, reversal, Rocuronium. Sugammadex"@en . "Sugammadex (Bridion\u00AE) - Prvn\u00ED zku\u0161enosti s antagonizac\u00ED m\u011Blk\u00E9ho bloku po pod\u00E1n\u00ED rokuronia"@cs . . . . "To study the reversal of moderate rocuronium-induced neuromuscular block as part of balanced general anaesthesia with sugammadex 2 mg/kg. Design: Clinical, observational, retrospective, non-interventional study. Setting: Department of Anaesthesiology, University Hospital. Materials and methods: The reversal of moderate rocuronium-induced neuromuscular block with sugammadex (2 mg/kg) was retrospectively studied. We used TOF stimulation of the ulnar nerve at 15-s intervals and measured the accelerometric response of the adductor pollicis muscle (TOF-Watch\u00AE SX). Following spontaneous recovery to TOF-count = 2, sugammadex (2 mg/kg) was administered and the reversal of the block was recorded. We transferred the data (TOF-ratio.T1) via a link to the computer and presented the results using descriptive statistics and graphs. Results: We analysed the data from 18 males and 14 females. The mean age was 46 years, mean weight 74 kg, mean height 170 cm and mean BMI 25.84 kg/m2."@en . "Sugammadex (Bridion\u00AE) - Our first experience with the reversal of moderate rocuronium-induced neuromuscular block"@en . "Sugammadex (Bridion\u00AE) - Prvn\u00ED zku\u0161enosti s antagonizac\u00ED m\u011Blk\u00E9ho bloku po pod\u00E1n\u00ED rokuronia" . "1"^^ . . "3"^^ . "CZ - \u010Cesk\u00E1 republika" . "Adamus, Milan" . "291018" . "Koutn\u00E1, Ji\u0159ina" . "Hrab\u00E1lek, Lum\u00EDr" . . . "Sugammadex (Bridion\u00AE) - Prvn\u00ED zku\u0161enosti s antagonizac\u00ED m\u011Blk\u00E9ho bloku po pod\u00E1n\u00ED rokuronia"@cs . . . "1214-2158" . . "I" . "Sugammadex (Bridion\u00AE) - Our first experience with the reversal of moderate rocuronium-induced neuromuscular block"@en . "[9F6D6A2BEFB1]" . "3" . . "Pro studium zru\u0161en\u00ED st\u0159edn\u011B rokuroniem vyvolan\u00E9 neuromuskul\u00E1rn\u00ED blok\u00E1dy jako sou\u010D\u00E1st vyv\u00E1\u017Een\u00E9 celkov\u00E9 anestezie se sugammadexem 2 mg / kg . Design: Klinick\u00E1 , pozorovac\u00ED , retrospektivn\u00ED , neinterven\u010Dn\u00ED studie. Nastaven\u00ED : Klinika anesteziologie , University Hospital. Materi\u00E1l a metody :Zru\u0161en\u00ED st\u0159edn\u00ED rokuroniem indukovan\u00E9 neuromuskul\u00E1rn\u00ED blok sugammadexem (2 mg / kg) byla retrospektivn\u00ED studie . Pou\u017Eili jsme TOF stimulaciloketn\u00EDho nervu v 15- s intervalech a m\u011B\u0159\u00EDaccelerometric reakce adductor pollicis sval ( TOF -Watch \u00AE SX ). Po spont\u00E1nn\u00EDho zotaven\u00ED k TOF- count = 2, sugammadexu (2 mg / kg) byl pod\u00E1n a zru\u0161en\u00ED bloku byl zaznamen\u00E1n . Jsme p\u0159esunulidata ( TOF - ratio.T1 ) p\u0159es odkaz na po\u010D\u00EDta\u010De a prezentov\u00E1nyv\u00FDsledky pomoc\u00ED popisn\u00E9 statistiky a grafy . V\u00FDsledky: Analyzovali jsme data z 18 mu\u017E\u016F a 14 \u017Een . Pr\u016Fm\u011Brn\u00FD v\u011Bk byl 46 let, pr\u016Fm\u011Brn\u00E1 hmotnost 74 kg , pr\u016Fm\u011Brn\u00E1 v\u00FD\u0161ka 170 cm a pr\u016Fm\u011Brn\u00FD BMI 25,84 kg/m2 ." . "RIV/00098892:_____/10:#0000131" . "Anesteziologie & intenzivn\u00ED medic\u00EDna" . . . . "Pro studium zru\u0161en\u00ED st\u0159edn\u011B rokuroniem vyvolan\u00E9 neuromuskul\u00E1rn\u00ED blok\u00E1dy jako sou\u010D\u00E1st vyv\u00E1\u017Een\u00E9 celkov\u00E9 anestezie se sugammadexem 2 mg / kg . Design: Klinick\u00E1 , pozorovac\u00ED , retrospektivn\u00ED , neinterven\u010Dn\u00ED studie. Nastaven\u00ED : Klinika anesteziologie , University Hospital. Materi\u00E1l a metody :Zru\u0161en\u00ED st\u0159edn\u00ED rokuroniem indukovan\u00E9 neuromuskul\u00E1rn\u00ED blok sugammadexem (2 mg / kg) byla retrospektivn\u00ED studie . Pou\u017Eili jsme TOF stimulaciloketn\u00EDho nervu v 15- s intervalech a m\u011B\u0159\u00EDaccelerometric reakce adductor pollicis sval ( TOF -Watch \u00AE SX ). Po spont\u00E1nn\u00EDho zotaven\u00ED k TOF- count = 2, sugammadexu (2 mg / kg) byl pod\u00E1n a zru\u0161en\u00ED bloku byl zaznamen\u00E1n . Jsme p\u0159esunulidata ( TOF - ratio.T1 ) p\u0159es odkaz na po\u010D\u00EDta\u010De a prezentov\u00E1nyv\u00FDsledky pomoc\u00ED popisn\u00E9 statistiky a grafy . V\u00FDsledky: Analyzovali jsme data z 18 mu\u017E\u016F a 14 \u017Een . Pr\u016Fm\u011Brn\u00FD v\u011Bk byl 46 let, pr\u016Fm\u011Brn\u00E1 hmotnost 74 kg , pr\u016Fm\u011Brn\u00E1 v\u00FD\u0161ka 170 cm a pr\u016Fm\u011Brn\u00FD BMI 25,84 kg/m2 ."@cs . . "Sugammadex (Bridion\u00AE) - Prvn\u00ED zku\u0161enosti s antagonizac\u00ED m\u011Blk\u00E9ho bloku po pod\u00E1n\u00ED rokuronia" . "RIV/00098892:_____/10:#0000131!RIV12-MZ0-00098892" . "21" .